Table 3.
FIS | AFB | P‐value | |||
---|---|---|---|---|---|
Mean age | 47.31 ± 12.26 | 46.14 ± 11.40 | 0.81 | ||
n | 19 | 48% | 21 | 53% | |
CI 95% | 5.51 | 4.88 | |||
Gender | 0.54 | ||||
Male | 12 | 63% | 11 | 52% | |
Female | 7 | 37% | 10 | 48% | |
Race/ethnicity | 0.76 | ||||
Non‐Hispanic White | 12 | 63% | 11 | 52% | |
African American | 6 | 32 | 6 | 29% | |
Hispanic | 1 | 5% | 3 | 14% | |
Other | 0 | 0% | 1 | 5% | |
Tobacco use | 0.26 | ||||
Current | 4 | 21% | 3 | 14% | |
Past | 9 | 47% | 6 | 29% | |
Never | 6 | 32% | 12 | 57% | |
Diabetes status | 0.99 | ||||
No | 16 | 84% | 16 | 76% | |
Type 1 | 0 | 0% | 1 | 5% | |
Type 2 | 3 | 16% | 4 | 19% | |
Wound location | 0.66 | ||||
Sacrum | 8 | 42% | 9 | 43% | |
Ischium | 8 | 42% | 10 | 48% | |
Trochanteric | 3 | 16% | 1 | 5% | |
Other | 0 | 0% | 1 | 5% | |
Number of wounds | 0.99 | ||||
Multiple | 7 | 37% | 8 | 38% | |
Single | 12 | 63% | 13 | 62% | |
Pre‐closure measurements | |||||
Length | 10.92 ± 4.51 | 9.05 ± 2.88 | 0.12 | ||
Width | 8.33 ± 3.61 | 6.19 ± 2.17 | 0.08 | ||
Depth | 4.03 ± 1.20 | 4.15 ± 1.90 | 0.56 | ||
History of wound | |||||
Recurrent | 4 | 21% | 4 | 19% | 0.99 |
Non‐recurrent | 15 | 79% | 17 | 81% | |
No previous Tx | 12 | 67% | 11 | 58% | 0.74 |
Previous Tx | 6 | 33% | 8 | 42% | |
NPWT | 3 | 60% | 4 | 67% | 0.45 |
AMWT | 2 | 40% | 0 | 0% | |
Hyperbaric | 0 | 0% | 1 | 17% | |
Biologics | 0 | 0% | 1 | 17% | |
Previous debrid. | 12 | 67% | 9 | 45% | 0.21 |
No debrid. | 6 | 33% | 11 | 55% | |
Prior closure | 2 | 11% | 5 | 25% | 0.41 |
No closure | 17 | 89% | 15 | 75% |
Abbreviations: AFB, air‐fluidised bed; AMWT, advanced moist wound therapy; CI, confidence interval; FIS, fluid immersion simulation; NPWT, negative pressure wound therapy.